Next generation financing instruments for early stage biotech ventures in Europe
Friday April 16th, 10:30 – 11:00, live from the studio at the Innovation for Health event, Koen Verhoef, Head of Knowledge Transfer & Contracting…
Press Release: NLC closes second funding round of Stepping Stone Fund to finance 40 new promising HealthTech ventures
Amsterdam, Thursday 25 March 2021 – We are very pleased to announce that we’ve closed the second funding round of our Stepping Stone Fund. With…
A lot to celebrate at PEP Health with Meghan Leaver
Recently there’s been a lot to celebrate at PEP Health. The Department of International Trade listed PEP on its ’25 to watch’ list and…
Five recommendations for optimal venture growth in your first six months!
With innovation becoming more and more important in today’s business world; the amount of aspiring entrepreneurs is growing and growing. We at NLC –…
Pressrelease: Concord Neonatal to expand sales internationally
Concord Neonatal, one of the ventures in NLC portfolio, has closed a new funding round, securing substantial funding with private investors. Concord Neonatal is…
Pressrelease: Intelligent ultrasound technique for diagnosing prostate cancer
Tilburg – 18 january 2021 – CbusineZ, the venture capital investor liaised to health insurer CZ, will together with a group of private investors,…
NLC concludes Framework Agreement with patent attorny firm De Vries & Metman
NLC has concluded a Framework Agreement with Amsterdam based patent attorney firm De Vries & Metman for their patent and IP protection services. “The best IP should be…
NLC’s current venture portfolio
NLC’s current venture portfolio
Inventor Brochure
Read the Inventor Brochure